Intrua Financial’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $3.85M | Buy |
20,726
+463
| +2% | +$85.9K | 0.52% | 33 |
|
2025
Q1 | $4.25M | Sell |
20,263
-1,688
| -8% | -$354K | 0.62% | 31 |
|
2024
Q4 | $3.9M | Buy |
21,951
+12
| +0.1% | +$2.13K | 0.6% | 35 |
|
2024
Q3 | $4.33M | Sell |
21,939
-4,660
| -18% | -$920K | 0.64% | 32 |
|
2024
Q2 | $4.56M | Buy |
26,599
+320
| +1% | +$54.9K | 0.68% | 29 |
|
2024
Q1 | $4.79M | Buy |
26,279
+495
| +2% | +$90.1K | 0.69% | 29 |
|
2023
Q4 | $4M | Buy |
25,784
+4,495
| +21% | +$697K | 0.58% | 39 |
|
2023
Q3 | $3.17M | Buy |
21,289
+402
| +2% | +$59.9K | 0.54% | 42 |
|
2023
Q2 | $2.81M | Buy |
20,887
+8,120
| +64% | +$1.09M | 0.48% | 49 |
|
2023
Q1 | $1.88M | Sell |
12,767
-723
| -5% | -$106K | 0.39% | 60 |
|
2022
Q4 | $2.01M | Buy |
13,490
+108
| +0.8% | +$16.1K | 0.46% | 51 |
|
2022
Q3 | $1.8M | Buy |
13,382
+124
| +0.9% | +$16.6K | 0.48% | 46 |
|
2022
Q2 | $2.03M | Sell |
13,258
-260
| -2% | -$39.8K | 0.43% | 51 |
|
2022
Q1 | $2.19M | Buy |
13,518
+4,317
| +47% | +$700K | 0.39% | 49 |
|
2021
Q4 | $1.25M | Sell |
9,201
-589
| -6% | -$79.8K | 0.22% | 102 |
|
2021
Q3 | $1.06M | Buy |
9,790
+3,538
| +57% | +$383K | 0.2% | 116 |
|
2021
Q2 | $711K | Sell |
6,252
-433
| -6% | -$49.2K | 0.17% | 129 |
|
2021
Q1 | $745K | Buy |
6,685
+2,550
| +62% | +$284K | 0.19% | 117 |
|
2020
Q4 | $443K | Buy |
4,135
+6
| +0.1% | +$643 | 0.2% | 111 |
|
2020
Q3 | $409K | Sell |
4,129
-1,922
| -32% | -$190K | 0.2% | 109 |
|
2020
Q2 | $573K | Buy |
+6,051
| New | +$573K | 0.22% | 99 |
|